Clinical trial · Observational
Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis
NCT01565811CI-TRIAL-00018998LNcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objective: To evaluate the role of regional lymphadenectomy in patients with colorectal cancer liver metastasis. Background: Lymph node status is 1 of the most important prognostic factors in oncologic surgery; however, the role of lymph node dissection remains unclear for colorectal cancer liver metastasis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer With Liver Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| perihepatic lymphadenectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Hepatic pedicle lymph node Involvement
- description
- Intervention Type: perihepatic lymphadenectomy(surgical procedure)
- interventionNames
- Procedure: perihepatic lymphadenectomy
Primary outcomes (1)
- measure
- complication rate
- timeFrame
- within 3months
Secondary outcomes (1)
- measure
- To evaluate prognostic significance of perihepatic LN involvement with overall survival and disease free survival
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. first hepatectomy; 2. age \<75 years; 3. absence of severe cardiovascular,pulmonary, or other associated diseases; 4. absence of other malignant disease; 5. absence of distant metastases secondary to colorectal cancer other than liver metastases (except a solitary peritoneal tumor that could be completely resected during hepatectomy); and 6. complete resection of liver metastases confirmed during surgery. Exclusion Criteria: 1. HNPCC 2. FAP 3. patient who refuses perihepatic lymphadnectomy 4. medical condition in which surgery cannot be tolerated
References
Publications (0)
Data not yet available
No reference posted for this study.